E-ISSN 2636-834X
 

Case Report 


Atomoxetine Treatment In A Patient With The Comorbidity Of Attention Deficit Hyperactivity Disorder And Fragile X Syndrome.

Esra Okyar , Leyla Bozatlı, Işık Görker.

Abstract
Fragile X Syndrome is a genetic disease defined by cognitive and behavioral characteristics that accompany apparent physical features. Male individuals are affected by this syndrome more severely, and it is the most common cause of mental retardation in men. The most common accompanying psychiatric conditions are mental retardation, autism, Attention Deficit Hyperactivity Disorder (ADHD), anxiety disorder, depression, sleep disorders and aggression. Anxiety, depression, shyness and social withdrawal are more common in female individuals. The diagnosis and treatment of the ADHD and selective mutism in a female adolescent patient who was Fragile X full mutant will be discussed in this case report.

Key words: Fragile X syndrome, ADHD, atomoxetine.


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Esra Okyar
Articles by Leyla Bozatlı
Articles by Işık Görker
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

EO, Bozatlı L, Gorker I, . Atomoxetine Treatment In A Patient With The Comorbidity Of Attention Deficit Hyperactivity Disorder And Fragile X Syndrome.. PBS. 2019; 9(4): 195-197. doi:10.5455/PBS.20190128114451


Web Style

EO, Bozatlı L, Gorker I, . Atomoxetine Treatment In A Patient With The Comorbidity Of Attention Deficit Hyperactivity Disorder And Fragile X Syndrome.. https://www.pbsciences.org/?mno=28313 [Access: December 04, 2023]. doi:10.5455/PBS.20190128114451


AMA (American Medical Association) Style

EO, Bozatlı L, Gorker I, . Atomoxetine Treatment In A Patient With The Comorbidity Of Attention Deficit Hyperactivity Disorder And Fragile X Syndrome.. PBS. 2019; 9(4): 195-197. doi:10.5455/PBS.20190128114451



Vancouver/ICMJE Style

EO, Bozatlı L, Gorker I, . Atomoxetine Treatment In A Patient With The Comorbidity Of Attention Deficit Hyperactivity Disorder And Fragile X Syndrome.. PBS. (2019), [cited December 04, 2023]; 9(4): 195-197. doi:10.5455/PBS.20190128114451



Harvard Style

, E. O. ., Bozatlı, L. . ., Gorker, I. . . & (2019) Atomoxetine Treatment In A Patient With The Comorbidity Of Attention Deficit Hyperactivity Disorder And Fragile X Syndrome.. PBS, 9 (4), 195-197. doi:10.5455/PBS.20190128114451



Turabian Style

, Esra Okyar , Leyla Bozatlı, Işık Gorker, and . 2019. Atomoxetine Treatment In A Patient With The Comorbidity Of Attention Deficit Hyperactivity Disorder And Fragile X Syndrome.. Psychiatry and Behavioral Sciences, 9 (4), 195-197. doi:10.5455/PBS.20190128114451



Chicago Style

, Esra Okyar , Leyla Bozatlı, Işık Gorker, and . "Atomoxetine Treatment In A Patient With The Comorbidity Of Attention Deficit Hyperactivity Disorder And Fragile X Syndrome.." Psychiatry and Behavioral Sciences 9 (2019), 195-197. doi:10.5455/PBS.20190128114451



MLA (The Modern Language Association) Style

, Esra Okyar , Leyla Bozatlı, Işık Gorker, and . "Atomoxetine Treatment In A Patient With The Comorbidity Of Attention Deficit Hyperactivity Disorder And Fragile X Syndrome.." Psychiatry and Behavioral Sciences 9.4 (2019), 195-197. Print. doi:10.5455/PBS.20190128114451



APA (American Psychological Association) Style

, E. O. ., Bozatlı, L. . ., Gorker, I. . . & (2019) Atomoxetine Treatment In A Patient With The Comorbidity Of Attention Deficit Hyperactivity Disorder And Fragile X Syndrome.. Psychiatry and Behavioral Sciences, 9 (4), 195-197. doi:10.5455/PBS.20190128114451